Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Notable Labs Ltd (Notable Labs) is a clinical-stage platform therapeutics company focused on developing predictive precision medicines for cancer patients. The company's activities focus on using its proprietary predictive precision medicines platform (PPMP) to bio-simulate a patient’s cancer treatment ex vivo and predict clinical responses. Its product is the PPMP, which integrates biological response data with computational algorithms to identify potential responders to cancer treatments. Notable Labs targets patients with cancer, particularly those with acute myeloid leukemia, aiming to improve treatment outcomes by identifying responsive patient subsets. The company operates primarily in the healthcare and biotechnology sectors. Notable Labs is headquartered in Foster City, California, the US.
Headquarters
United States of America
Address
320 Hatch Drive, Foster City, California, 94404
Website
notablelabs.com
Telephone
1 415 8512410
No of Employees
16
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
NTBLQ (OTC)
Revenue (2023)
$310,000
-52.9%
(2023 vs 2022)
EPS
XYZ
Net Income (2023)
XYZ
65.1%
(2023 vs 2022)
Net Profit Margin (2023)
XYZ
26.0%
(2023 vs 2022)
* As of and is in US$
Notable Labs Ltd premium industry data and analytics
Products and Services
| Products |
|---|
| Predictive Precision Medicine Platform (PPMP) |
Competitor Comparison
| Key Parameters | Notable Labs Ltd | Taro Pharmaceutical Industries Ltd | Champions Oncology Inc | BioLineRx Ltd | Accelerated Evolution Biotechnologies Ltd |
|---|---|---|---|---|---|
| Headquarters | United States of America | Israel | United States of America | Israel | Israel |
| City | Foster City | Haifa | Hackensack | Modi'in-Maccabim-Re'ut | Ness-Ziona |
| State/Province | California | - | New Jersey | - | Sharon (Netanya) |
| No. of Employees | 16 | 1,554 | 213 | 28 | - |
| Entity Type | Public | Private | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Thomas Bock | Chief Executive Officer | Senior Management | - | - |
| Scott McPherson | Chief Financial Officer | Senior Management | - | - |
| Joseph Wagner, PhD | Chief Scientific Officer | Senior Management | 2024 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer